Jeegar Pravinkumar Patel - 22 Jun 2026 Form 4 Insider Report for Evommune, Inc. (EVMN)

Reporting relationship: Chief Scientific Officer
Issuer ticker: EVMN
Reported as of: 22 Jun 2026
Net transaction value: -$33,480
SEC form: 4
Accepted by SEC: 24 Jun 2026, 20:00:25 UTC
Prior SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Gregory S. Moss, Attorney-in-Fact

Key filing fact

Jeegar Pravinkumar Patel filed Form 4 for Evommune, Inc. (EVMN) on 24 Jun 2026.

Key facts

This page summarizes Jeegar Pravinkumar Patel's Form 4 filing for Evommune, Inc. (EVMN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jun 2026, 20:00.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: -$33,480.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002092017 Primary reporting owner

Patel Jeegar Pravinkumar

Relationship: Chief Scientific Officer
Address: C/O EVOMMUNE, INC., 1891 PAGE MILL ROAD, PALO ALTO
Signature: /s/ Gregory S. Moss, Attorney-in-Fact
Signature date: 24 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVMN transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,488
Change %: +3.2%
Price: $3.84^*
Shares after: 47,891
Date: 22 Jun 2026
Ownership: Direct
Footnotes: F1

EVMN transaction

Common Stock

Sale

Transaction value: $33,480
Shares: -1,488
Change %: -3.1%
Price: $22.50
Shares after: 46,403
Date: 22 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVMN transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -1,488
Change %: -5.1%
Price: $0.000000^*
Shares after: 27,842
Date: 22 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,488
Exercise price: $3.84
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transactions were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.

Footnote F2

One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.